Company intelligence / Profile preview
MIP Pharma
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
Overview
MiP Pharma commercially supplies generic antibiotics, OTC drugs, and medical devices, with especially high market share in the hospital segment for parenteral cephalosporins (up to 40%). The company is recognized for reliable delivery and has received accolades as "Best Pharmaceutical Supplier" for hospitals in Germany[1][4].
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small moleculeDrug (generic)Medical device
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on MIP Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MIP Pharma.